Ensitrelvir reduced transmission of SARS-CoV-2 by 67% when given to uninfected household contacts of a person with COVID-19 ...

W hen COVID-19 first emerged more than a year and a half ago in Wuhan, China, experts, seeing hospital beds filling up with patients in need of ventilators, initially thought it was a lung disease.

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

The COVID-19 pandemic highlighted the urgent need for effective therapeutic agents against SARS-CoV-2. Although vaccines ...

“In addition to a flu model, using the mouse version of SARS-CoV-2, doing both models genetically and both models ... metabolism in disorders such as diabetes and non-alcoholic fatty liver disease ...

When the COVID-19 pandemic first began, we saw how quickly the SARS-CoV-2 virus evolved. New variants emerged with mutations that increased transmissibility or helped the virus evade our immune ...

liver and spleen. However, no evidence for substantial infection of neurons by SARS-CoV-2 was found. This suggests that neurological complications of COVID-19 may not be due to a classical ...

In the graphics that follow, Scientific American presents detailed explanations, current as of mid-June, into how SARS-CoV-2 sneaks inside human cells, makes copies of itself and bursts out to ...

A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep ...